Press release
Global High BP/Hypertension Drugs and Device Market Forecast 2018-2023
The high blood pressure/hypertension market is expected to grow significantly during the forecast period (2018-2023). High blood pressure or hypertension occurs when there is resistance in the blood flow due to narrow arteries. High blood pressure is a major health problem that has complications which includes heart diseases, kidney diseases, hardening of the arteries, eye damages and strokes. The hypertension market is growing significantly due to various factors such as increasing incidences of hypertension and government funded programs and initiatives. Rising lifestyle related health issues and obesity among people due to consumption of fast foods and unhealthy food also drive the growth of the market. Increasing investment in the field of research and development helps for the growth of the market. Changing and hectic lifestyle of people due to consumption of alcohol and smoking, technological advancement in blood pressure monitoring devices, and increasing healthcare expenditure creates future opportunity for the expansion of the market. Although factors such as inadequate healthcare infrastructure in many underdeveloped and developing countries hinders the hypertension drugs monitoring device market growth.
For browse full report at: https://www.omrglobal.com/industry-reports/hypertension-drugs-monitoring-device-market/
The market can be segmented on the basis of drugs, monitoring devices and end users. On the basis of drugs, the market is subdivided as pulmonary hypertension drugs and systemic hypertension drugs. According to the monitoring devices, the market is diversified as aneroid sphygmomanometers; mercury sphygmomanometer, ambulatory BP monitors and digital devices. And as per end users, the market is sub-segmented as hospitals and clinics and homecare.
Geographically, the market is divided into North America, Europe, Asia Pacific and Rest of the world. North America covers the largest market share due to developed technology and adequate healthcare infrastructure. Asia Pacific is considered as the fastest growing region.
The key players contributing to the global market comprise of Eli Lilly and Company, Pfizer Inc., Bayer AG, Novartis International AG, Merck & Co. Inc., Sanofi S.A., Reata pharmaceuticals Inc., Lung Biotechnology PBC, and others. One of the market players, Pfizer Inc., in April 2017, collaborated with the international nonprofit organization Population Services International (PSI) for expanding access to life-saving hypertension medicines and treatment services in Vietnam and Myanmar.
The report Covers:
Comprehensive research methodology of global Hypertension drugs monitoring Device Market.
This report also includes detailed and extensive market overview with key analyst insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Hypertension drugs monitoring Device Market
Insights about market determinants which are stimulating the Hypertension drugs monitoring Device Market
Related reports: https://www.omrglobal.com/reports-category/medical-devices/
For More Update Follow LinkedIn: www.linkedin.com/company/omr-global-research/
About orion market research:
OMR is a market research company known for its qualitative and quantitative research reports. The company aims to provide business insights for decision making to the global clients. OMR provides syndicated and customized research reports, company profiling, consulting and other research-based services to global clients. The "Orion" in the name signifies rising up in the sky, the company is committed to provide valuable insights that will help its clients to rise and shine. OMR provide customer-centric reports which facilitate the subscribers to know their touch points which can be capitalized for their revenue growth and to gain a competitive edge.
Contact us
Orion Market Research Pvt Ltd
116, Shagun Arcade, Vijay Nagar Square
Indore – India- 452010
Email: info@omrglobal.com, support@omrglobal.com
India: +91-780-304-0404, +91-917-982-8694
Global: +1-646-755-7667
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global High BP/Hypertension Drugs and Device Market Forecast 2018-2023 here
News-ID: 1213500 • Views: …
More Releases from Orion Market Research
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033.
AI-Enabled Imaging Modalities Market Overview
The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including…
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of…
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the…
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034.
SNP genotyping Market Overview
The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This…
More Releases for Hypertension
Hypertension Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Hypertension Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Hypertension pipeline landscape. It covers the Hypertension pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hypertension pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Hypertension Pipeline Report
• DelveInsight's Hypertension…
Hypertension Drugs Market - Breaking the Pressure: Hypertension Drugs Redefining …
Newark, New Castle, USA: The "Hypertension Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Hypertension Drugs Market: https://www.growthplusreports.com/report/hypertension-drugs-market/8760
This latest report researches the industry structure, sales, revenue,…
Hypertension Management Devices Market: Rise in Prevalence of Resistant Hyperten …
Market Analysis and Insights of Hypertension Management Devices Market
Hypertension Management Devices Market to account USD 9.50 billion and growing at a CAGR of 7.27% by 2032. Although there are still numerous variations available, the major market players are currently developing and testing clinical versions of hypertension treatment devices. Due to the lack of available effective medications, these medical devices are being created with the primary goal of managing cardiovascular illnesses…
Anti-hypertension - Drug Pipeline Landscape, 2022
Hypertension also known as high blood pressure is a condition where the force of blood pushing against the arterial walls of heart is consistently higher than the normal. Hypertension can be identified as primary/essential (without a known cause such as age, genetics, sedentary lifestyle, alcohol consumption, high sodium intake etc.) and secondary (due to an underlying condition as its cause such as congenital heart defects, kidney diseases, endocrinal issues, side…
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027.
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC…
Renal Hypertension: Diagnosis & Treatment
“Hypertension & Cardiovascular disease after Kidney Transplantation” is one of the workshops to be conducted by Dr. Hossein Tabriziani of Loma Linda University, USA under the session ‘Renal Hypertension’ at the meeting 2nd International Conference on Hypertension & Healthcare which is going to be held at Amsterdam, Netherlands during September 11-13, 2017.
High blood pressure is a leading cause of kidney disease and kidney failure ESRD (end stage renal disease). Hypertension…
